ZV
Zubairali Valiyathodi
About Zubairali Valiyathodi
Data last updated:
Zubairali Valiyathodi is a Director at Orient Drugs Private Limited (since 2016). The company operates in Pharma. Orient Drugs Private Limited reported revenue of ₹7.95 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Orient Drugs Private Limited U24231KL1997PTC011301 | Director | 04 Mar 2016 | 1997 | ₹7.95 Cr (FY 2025) | Active |
Board colleagues of Zubairali Valiyathodi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abdu Avulan | 01827943 | Orient Drugs Private Limited | Managing Director |
| Fathima Sheikmoossa Avulan | 07460057 | Orient Drugs Private Limited | Director |
| Favas Avulan | 06759875 | Orient Drugs Private Limited | Director |
| Jameela Konndla Badiuzzaman | 07460071 | Orient Drugs Private Limited | Director |
| Mumtaz Pothaparambath | 07460080 | Orient Drugs Private Limited | Director |
| Naseer Kalappaden | 01827936 | Orient Drugs Private Limited | Director |
| Shibibiyya Mecheri | 09568099 | Orient Drugs Private Limited | Director |
| Ummer Thekkepath | 07463474 | Orient Drugs Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Zubairali Valiyathodi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zubairali Valiyathodi
Zubairali Valiyathodi currently holds 1 directorship: Orient Drugs Private Limited (Director, since 04 Mar 2016, revenue ₹7.95 Cr (FY 2025)).
Zubairali Valiyathodi was first appointed on 04 Mar 2016 as Director at Orient Drugs Private Limited.
The current boards of Zubairali Valiyathodi's companies include Abdu Avulan (Orient Drugs Private Limited), Fathima Sheikmoossa Avulan (Orient Drugs Private Limited), Favas Avulan (Orient Drugs Private Limited), Jameela Konndla Badiuzzaman (Orient Drugs Private Limited), Mumtaz Pothaparambath (Orient Drugs Private Limited), Naseer Kalappaden (Orient Drugs Private Limited), among others.